AOR

The Archives of Ophthalmological Research aims to publish issues related to publish articles of the highest scientific and clinical value at an international level, and accepts articles on these topics. The target audience of the journal included specialists and physicians working in ophthalmology, and other health professionals interested in these fields.

EndNote Style
Index
Original Article
Relationship between retinal vein occlusion and ocular biometric parameters
Aims: To compare the biometric characteristics of eyes with unilateral retinal vein occlusion (RVO) with unaffected eyes of patients and eyes of healthy participants
Methods: The affected eyes (Group 1) and unaffected eyes (Group 2) of 57 patients with unilateral RVO and the right eyes of 57 healthy participants (Group 3) were included in the study. Axial length (AL), vitreous length (VL), anterior chamber depth (ACD) and lens thickness (LT) measurements by ultrasonic biometry were retrospectively analyzed.
Results: Mean AL was 22.61±0.89 mm in Group 1, 22.93±0.88mm in Group 2, and 23.10±0.90mm in Group 3. Mean AL was found to be lower in Group 1 compared to both Group 2 and Group 3 (p<0.001, p=0.005, respectively). Mean VL values were 15.28±1.11 mm in Group 1, 15.36±1.44 mm in Group 2, and 15.97±1.01 mm in Group 3. Mean VL was statistically significantly shorter in Group 1 than both Group 2 and Group 3 (p=0.026 and p=0.001, respectively). Mean VL was statistically significantly lower in Group 2 than in Group 3 (p=0.015). In Group 1, the mean ACD was 3.02±0.41 mm, in Group 2 the mean ACD was 3.15±0.50 mm, and in Group 3 the mean ACD was 3.01±0.32 mm. While the mean ACD of Group 1 was lower than that of Group 2 (p<0.001), there was no statistically significant difference between Group 1 and Group 3 and between Group 2 and Group 3 (p=0.696 and p=0.092, respectively). Mean LT was similar in all groups and no statistically significant difference was found between the groups (p>0.05)
Conclusion: Ocular causes of RVO may include short AL and short VL.


1. Romano F, Lamanna F, Gabrielle PH, et al. Update on retinal vein occlusion. Asia Pac J Ophthalmol (Phila.) 2023;12(2):196-210.
2. Becker B, Post LT, Jr. Retinal vein occlusion. Clinical and experimental observations. Am J Ophthalmol. 1951;34(5 1):677-686.
3. Song P, Xu Y, Zha M, Zhang Y, Rudan I. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019;9(1):010427.
4. Noma H, Yasuda K, Shimura M. Cytokines and pathogenesis of central retinal vein occlusion. J Clin Med. 2020;9(11):3457.
5. Jaulim A, Ahmed B, Khanam T, Chatziralli IP. Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina. 2013; 33(5):901-910.
6. Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost. 2005;93(6):1021-1026.
7. O&rsquo;Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008; 126(5):692-699.
8. Aggarwal RS, Mishra VV, Aggarwal SV. Oral contraceptive pills: a risk factor for retinal vascular occlusion in in-vitro fertilization patients. J Hum Reprod Sci. 2013;6(1):79-81.
9. Ashkenazy N, Patel NA, Sridhar J, et al. Hemi- and central retinal vein occlusion associated with COVID-19 infection in young patients without known risk factors. Ophthalmol Retina. 2022;6(6):520-530.
10. Yin X, Li J, Zhang B, Lu P. Association of glaucoma with risk of retinal vein occlusion: a meta-analysis. Acta Ophthalmol. 2019;97(7):652-659.
11. Coşkun M, Anayol MA, Toklu Y, Altıntaş AGK, Şimşek Ş. Retina ven dal tıkanıklığı olan olgularda aksiyel uzunluk, &ouml;n kamara derinliği ve optik disk &ccedil;aplarının incelenmesi. J Retina Vitreous. 2008;16:2.
12. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam eye study. Trans Am Ophthalmol Soc. 2000;98:133-143.
13. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains eye study. Arch Ophthalmol. 1996;114(10):1243-1247.
14. Ip M, Hendrick A. Retinal vein occlusion review. Asia Pac J Ophthalmol (Phila). 2018;7(1):40-45.
15. Ghoghari H, Rizvi SF, Loya H, Razzak K. Axial length, a risk factor for retinal vein occlusion: a case control study. J Pak Med Assoc. 2019; 69(12):1800-1802.
16. Szigeti A, Schneider M, Ecsedy M, Nagy ZZ, R&eacute;cs&aacute;n Z. Association between retinal vein occlusion, axial length and vitreous chamber depth measured by optical low coherence reflectometry. BMC Ophthalmol. 2015;15:45.
17. &Ccedil;iloğlu E, K&ouml;ker &Ouml;F, &Ouml;zcan AA. Retina ven tıkanıklığında g&ouml;z i&ccedil;i basın&ccedil; ve aksiyel uzunluk değerlendirilmesi. J Glaucoma-Cataract. 2013;8:2.
18. Vural GS, Karahan E. Central corneal thickness, axial length, anterior chamber and optic disc structure in patients with central and branch retinal vein occlusion. Eur J Ophthalmol. 2022:11206721221131705.
19. Longo A, Avitabile T, Uva MG, et al. Optic nerve head in central retinal vein occlusion by spectral-domain OCT. Eur J Ophthalmol. 2017;27(4): 485-490.
20. Feist RM, Ticho BH, Shapiro MJ, Farber M. Branch retinal vein occlusion and quadratic variation in arteriovenous crossings. Am J Ophthalmol. 1992;113(6):664-668.
21. Wu SC, Lee YS, Wu WC, Chang SH. Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion. BMC Ophthalmol. 2016;16:68.
Volume 2, Issue 1, 2025
Page : 1-4
_Footer